Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models
Abstract Understanding potential differences in vaccine-induced protection between demographic subgroups is key for vaccine development. Vaccine efficacy evaluation across these subgroups in phase 2b or 3 clinical trials presents challenges due to lack of precision: such trials are typically designe...
Saved in:
| Main Authors: | Julie Dudášová, Zdeněk Valenta, Jeffrey R. Sachs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-024-00937-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sequestration of gene products by decoys enhances precision in the timing of intracellular events
by: Kuheli Biswas, et al.
Published: (2024-11-01) -
Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon
by: Abeer Zeitoun, et al.
Published: (2024-11-01) -
Efficacy and immune-related adverse event associations in avelumab-treated patients
by: Arun Rajan, et al.
Published: (2020-10-01) -
Strategies for improving the management of immune-related adverse events
by: James L Gulley, et al.
Published: (2020-10-01) -
Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
by: Yiming Li, et al.
Published: (2024-12-01)